May 19th 2021, Dublin: IDA Ireland welcomes the announcement today by Pfizer that it is to manufacture a Covid-19 vaccine drug substance at its Grange Castle facility in Dublin.
Pfizer is to invest some $40M in the expansion of the Grange Castle site to allow for the extra production that will be part of the global Pfizer-BioNTech COVID-19 Vaccine supply chain network, contributing to the worldwide supply of the vaccine.
75 new roles are to be created as a result.
Commenting today, An Taoiseach, Micheal Martin said: “I’m delighted to welcome today’s announcement by Pfizer that it will shortly begin production of COVID-19 vaccine components in Ireland, with the associated investment of c$40 million and the creation of 75 jobs at Grange Castle in Dublin. This is a historic announcement, which builds on the extraordinary success story of Pfizer’s over 50 year manufacturing presence here in Ireland. As we rapidly step up vaccine roll out, in Ireland, in Europe and across the globe, today’s news is a fantastic development that will see Ireland fully play its part in this generational challenge.”
Tanaiste and Minister for Business, Enterprise & Innovation, Leo Varadkar said: “Ireland is globally recognised as a centre of excellence for the Life Sciences and this investment is a real vote of confidence in us and our capacity. With this announcement, we will have a central role to play in the Covid-19 response, helping to produce this life saving vaccine in Dublin, creating 75 new, highly skilled jobs. These vaccines have saved countless lives and I’m really happy Pfizer has chosen to produce components of them here.”
IDA Ireland CEO Martin Shanahan said:
it underlines the importance of the pharma sector in Ireland and demonstrates the capability of the biological sector here. “This is most welcome news and a strong vote of confidence in the skills, expertise and capability to manufacture this mRNA drug substance substance here. Pfizer has played an important part to date in the delivery of vaccine to help in the fight against Covid-19 and it is great that the company’s efforts will now be assisted by the production of this mRNA drug substance from Ireland. The 75 jobs being created at the Grange Castle facility are also extremely welcome.”
Press & PR Manager,
Ellen.firstname.lastname@example.org 087 4112084